Publication: Implant survival in patients with neuropsychiatric, neurocognitive, and neurodegenerative disorders: A meta-analysis
Loading...
Date
2021
Journal Title
National Journal of Maxillofacial Surgery
Journal ISSN
Volume Title
Publisher
Wolters Kluwer Medknow Publications
Abstract
Neurologic disorders impede oral hygiene measures and routine clinical follow-up, along with the various drugs used may jeopardise oral health and the peri-implant tissue health. A total of 7 studies were considered eligible for the current systematic review. The overall estimated effect was categorized as significant where P < 0.05. Funnel plot was used to assess the publication bias within the studies. Difference in means was used as principal summary measure. P value <0.05 was considered as statistically significant. 1069 implants survived in test group and 4677 implants survived in control group (odds ratio: 2.58, 95% CI: 1.93-3.43) indicating significant success in patient without any disorders or taking medications for these disorders. Subgroup analysis was done to check the implant survival rate in patients taking selective serotonin reuptake inhibitors (SSRI) compared with SSRI non-users. Subgroup analysis showed that SSRI non-users had higher implant survival rate than patients taking SSRI (odds ratio: 2.45, 95% CI: 1.82-3.31). Serotonin significantly inhibits bone mineralization and osteoblast differentiation. The presence of any form of neuropsychiatric or neuromuscular disorders precludes proper oral hygiene and may contribute towards implant failure. � 2021 National Journal of Maxillofacial Surgery.
Description
Keywords
Implant survival, Implants and neurologic patients, Neuropsychiatric disorders